MELISSA DAVIS: Open Payments
NPI 1558557132 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$119,923 in 314 payments from 21 companies in 2025. Trend: 2023 $72,976 · 2024 $110,528 · 2025 $119,923
Speaker / faculty: $67,300Consulting: $29,355Travel & lodging: $15,535Food & beverage: $5,935Honoraria: $1,600Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 68 | $43,660 |
| Lilly USA, LLC | 68 | $33,701 |
| Arcutis Biotherapeutics, Inc. | 38 | $21,270 |
| ABBVIE INC. | 37 | $8,702 |
| Eli Lilly and Company | 5 | $4,550 |
| UCB, Inc. | 18 | $2,652 |
| LNHC, Inc | 3 | $1,698 |
| Galderma Laboratories, L.P. | 8 | $1,407 |
| Novartis Pharmaceuticals Corporation | 23 | $498 |
| Kowa Pharmaceuticals America, Inc. | 1 | $350 |
Products named: TREMFYA, EBGLYSS, Zoryve, SKYRIZI, Bimzelx, ZELSUVMI, NEMLUVIO, DUPIXENT.
Industry payments across KY — which companies pay providers there.
